Needham & Company Raises Price Target on Sapiens (SPNS) Following a Solid 4Q and Upbeat Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Needham & Company Raises Price Target on Sapiens (SPNS) Following a Solid 4Q and Upbeat Guidance
February 17, 2016 5:56 AM EST
Sapiens (NASDAQ: SPNS) reported Q4 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $48.7 million versus the consensus estimate of $48.18 million.
GUIDANCE:
Sapiens sees FY2016 revenue of $207-211 million, versus the consensus of $205.2... More
February 16, 2016 3:29 PM EST
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
PPI - Street sees (0.2%)Core PPI - Street sees 0.0%Housing Starts - Street sees 1.171MBuilding Permits - Street sees 1.200M
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%
Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
